260 related articles for article (PubMed ID: 27074562)
1. FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
Kelleher FC; O'Sullivan H
Oncotarget; 2016 Jul; 7(27):42792-42804. PubMed ID: 27074562
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis.
Eisinger-Mathason TS; Mucaj V; Biju KM; Nakazawa MS; Gohil M; Cash TP; Yoon SS; Skuli N; Park KM; Gerecht S; Simon MC
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):E3402-11. PubMed ID: 26080399
[TBL] [Abstract][Full Text] [Related]
3. The Forkhead box transcription factor FOXM1 is required for the maintenance of cell proliferation and protection against oxidative stress in human embryonic stem cells.
Kwok CT; Leung MH; Qin J; Qin Y; Wang J; Lee YL; Yao KM
Stem Cell Res; 2016 May; 16(3):651-61. PubMed ID: 27062359
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
Creager AJ; Cohen JA; Geradts J
Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
[TBL] [Abstract][Full Text] [Related]
5. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
Zayed H; Petersen I
Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
[TBL] [Abstract][Full Text] [Related]
6. Pro-proliferative FoxM1 is a target of p53-mediated repression.
Barsotti AM; Prives C
Oncogene; 2009 Dec; 28(48):4295-305. PubMed ID: 19749794
[TBL] [Abstract][Full Text] [Related]
7. Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks.
Fischer M; Grossmann P; Padi M; DeCaprio JA
Nucleic Acids Res; 2016 Jul; 44(13):6070-86. PubMed ID: 27280975
[TBL] [Abstract][Full Text] [Related]
8. Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.
Chand V; Pandey A; Kopanja D; Guzman G; Raychaudhuri P
Mol Cancer Res; 2019 May; 17(5):1063-1074. PubMed ID: 30814128
[TBL] [Abstract][Full Text] [Related]
9. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.
Nakamura S; Hirano I; Okinaka K; Takemura T; Yokota D; Ono T; Shigeno K; Shibata K; Fujisawa S; Ohnishi K
Carcinogenesis; 2010 Nov; 31(11):2012-21. PubMed ID: 20823107
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
[TBL] [Abstract][Full Text] [Related]
11. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 facilitates breast cancer cell stemness and migration in YAP1-dependent manner.
Sun HL; Men JR; Liu HY; Liu MY; Zhang HS
Arch Biochem Biophys; 2020 May; 685():108349. PubMed ID: 32209309
[TBL] [Abstract][Full Text] [Related]
13. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.
Wierstra I
Adv Cancer Res; 2013; 118():97-398. PubMed ID: 23768511
[TBL] [Abstract][Full Text] [Related]
15. Two-fold elevation of expression of FoxM1 transcription factor in mouse embryonic fibroblasts enhances cell cycle checkpoint activity by stimulating p21 and Chk1 transcription.
Tan Y; Chen Y; Yu L; Zhu H; Meng X; Huang X; Meng L; Ding M; Wang Z; Shan L
Cell Prolif; 2010 Oct; 43(5):494-504. PubMed ID: 20887555
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
[TBL] [Abstract][Full Text] [Related]
17. Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma.
Wang Z; Zheng Y; Park HJ; Li J; Carr JR; Chen YJ; Kiefer MM; Kopanja D; Bagchi S; Tyner AL; Raychaudhuri P
Mol Cancer Ther; 2013 May; 12(5):759-67. PubMed ID: 23427295
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma.
Yu M; Tang Z; Meng F; Tai M; Zhang J; Wang R; Liu C; Wu Q
Tumour Biol; 2016 Jan; 37(1):1289-97. PubMed ID: 26289845
[TBL] [Abstract][Full Text] [Related]
19. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
